Moreover, CENPL was detected as one of the novel hub genes and served as a prognostic marker candidate in breast cancer [48], and high expression of CCNB2 in breast carcinoma showed an association with disadvantageous clinical outcomes [49]. The gene discussed is CCNB2; the disease is breast cancer.